These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 335867)

  • 1. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.
    Aronow WS; Greenfield RS; Alimadadian H; Danahy DT
    Am J Cardiol; 1977 Nov; 40(5):789-93. PubMed ID: 335867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of trimazosin on hemodynamics in chronic heart failure.
    Orlando JR; Danahy DT; Lurie M; Aronow WS
    Clin Pharmacol Ther; 1978 Nov; 24(5):531-6. PubMed ID: 359215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term vasodilator therapy with trimazosin in chronic cardiac failure.
    Weber KT; Kinasewitz GT; West JS; Janicki JS; Reichek N; Fishman AP
    N Engl J Med; 1980 Jul; 303(5):242-50. PubMed ID: 6104295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic alpha-adrenoceptor blockade with trimazosin in congestive heart failure.
    Kirlin PC; Das S; Pitt B
    Int J Cardiol; 1985 May; 8(1):89-92. PubMed ID: 2987137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.
    Franciosa JA; Weber KT; Levine TB; Kinasewitz GT; Janicki JS; West J; Henis MM; Cohn JN
    Am Heart J; 1982 Sep; 104(3):587-94. PubMed ID: 7051796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of refractory heart failure with trimazosin.
    Taylor DJ; Bell AJ
    Eur Heart J; 1981 Apr; 2(2):127-33. PubMed ID: 7274272
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimazosin in chronic congestive heart failure: improved left ventricular function at rest and during exercise.
    Ports TA; Chatterjee K; Wilkinson P; Avakian D; Parmley WW
    Am Heart J; 1983 Nov; 106(5 Pt 1):1036-42. PubMed ID: 6139004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
    Taylor CR; Baird JR; Blackburn KJ; Cambridge D; Constantine JW; Ghaly MS; Hayden ML; McIlhenny HM; Moore PF; Olukotun AY; Pullman LG; Salsburg DS; Saxton CA; Shevde S
    Am Heart J; 1981 Sep; 102(3 Pt 2):515-32. PubMed ID: 7023221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of essential hypertension with trimazosin, a new vasodilator agent.
    Vlachakis ND; Mendlowitz M; De Guzman de Guzman D
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):564-9. PubMed ID: 808379
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease.
    Awan NA; Hermanovich J; Vera Z; Amsterdam EA; Mason DT
    Clin Pharmacol Ther; 1982 Mar; 31(3):290-6. PubMed ID: 7060312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.
    Weber KT; Andrews V; Kinasewitz GT; Janicki JS; Fishman AP
    Am Heart J; 1981 Sep; 102(3 Pt 2):569-77. PubMed ID: 6115574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.
    Higginbotham MB; Morris KG; Bramlet DA; Coleman RE; Cobb FR
    Am J Cardiol; 1983 Oct; 52(7):782-8. PubMed ID: 6353898
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.